On 12 July 2017, the Healthcare and Life Sciences team of FTI Consulting’s Brussels office hosted an event entitled, “Brexit and Life Sciences: Intensive Care Needed?”, bringing together experts from the UK and Brussels to discuss the impact of Brexit on the healthcare sector and what it means for businesses on both sides of the channel.
The panel was moderated by FTI Consulting’s Patricia Hewitt, who previously served as the UK Secretary of State for Health. Speakers included Mike Bewick, a senior clinical advisor to the Healthcare Solutions team at FTI Consulting, and former Deputy Medical Director of NHS England, Elizabeth Kuiper, Director for European Affairs at the European Federation of Pharmaceutical Industries and Associations (EFPIA), David Earnshaw, head Public Policy Europe & Canada at MSD, and Gian Marco Currado, the social and environment counsellor, overseeing a wide range of areas, including healthcare, at the UK’s Permanent Representation to the EU (UKREP).
The event brought together over 30 healthcare and policy stakeholders, including pharmaceutical companies, medical device and technology companies, trade associations, an NHS representative and the European Commission.
In this snapshot we give an overview of the discussion and assess the potential impact of life sciences in the EU.
Katie Brown is Senior Director, and Zachary Burnside is Consultant at FTI Consulting in Brussels